These two PC sufferers with a genetic linkage of BRCA1/2 mutations were both found to have low volume Gleason score 6 diseases, and managed by active surveillance for over 5 years without clinical evidence of disease progression. The gene discussed is BRCA1; the disease is pachyonychia congenita.